Shoulder joint disease
Conditions
Interventions
The infraspinatus teres minor block group:Induce with 20ml of 0.375% ropivacaine (12.5ml of injected normal saline + 7.5ml of ropivacaine hydrochloride injection) for ultrasound-guided teres minor blo
Interscalene brachial plexus block group:Induce with 20ml of 0.375% ropivacaine (12.5ml of injected normal saline + 7.5ml of ropivacaine hydrochloride injection) for interscalene brachial plexus block
Sponsors
First Affiliated Hospital of University of Science and Technology of China
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1.Age 18-65 years 2.Patients scheduled for elective shoulder arthroscopy
Exclusion criteria
Exclusion criteria: 1.History of obstructive or restrictive pulmonary disease; 2. BMI > 35 kg/m²; 3. Coagulation dysfunction; 4. Liver or kidney failure; 5. Pregnancy; 6. Allergy to local anesthetics; 7. Chronic opioid use; 8. History of neck or supraclavicular surgery; 9. Previous neurological deficits or neuropathies affecting the brachial plexus; 10. Patients classified as ASA IV or higher; 11. Patients undergoing revision, irrigation, and debridement surgery; 12. Poorly controlled hypertension
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Numerical rating scale;Rescue analgesic dose; | — |
Secondary
| Measure | Time frame |
|---|---|
| Systolic pressure;Diastolic pressure;Heart rate;First press time of PCIA;Total number of presses for PCIA;Effective number of presses for PCIA;Diaphragmatic mobility;Level of inflammatory factors; | — |
Countries
China
Contacts
Public ContactYuanhang Luan
First Affiliated Hospital of University of Science and Technology of China
Outcome results
None listed